Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling

HIGHLIGHTS

• who: Bu00e9nu00e9dicte Rousseau from the State University of New Jersey, Poultry Farm Lane, New Brunswick, NJ, USA have published the Article: Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling, in the Journal: (JOURNAL)
• what: The authors show here that in cells the reduction in expression B2AR and MOR by genetic and tools leads to a less aggressive phenotype of cells in vitro and in animal xenografts. The authors demonstrate in this study that B2AR and MOR interact . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.